Corpus Intelligence IC Memo — REAGAN MEMORIAL HOSPITAL 2026-04-26 15:53 UTC
IC Memo — REAGAN MEMORIAL HOSPITAL
Investment Committee Memorandum | TX | 7 beds | Grade D | EBITDA uplift $531K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

REAGAN MEMORIAL HOSPITAL

CCN 451301 | REAGAN, TX | 7 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

REAGAN MEMORIAL HOSPITAL is a 7-bed community hospital in REAGAN, TX with $7.1M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 82.7% Medicare, 0.0% Medicaid, and 17.3% commercial.

Thesis: Turnaround. Our ML models identify $531K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -110.8% (+749bps).

Net Revenue HCRIS$7.1M
Current EBITDA COMPUTED$-8.4M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS5.0%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS98.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
23
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -100.0% places it below the state median. Among 23 size-comparable peers (4-14 beds), the median margin is -40.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (4-14), prioritizing same-state peers. 23 hospitals in the comp set.

HospitalStateBedsRevenueMargin
REAGAN MEMORIAL HOSPITAL (Target)TX7$7.1M-100.0%
HERITAGE PARK SURGICAL HOSPITATX12$52.5M19.2%
BAYTOWN MEDICAL CENTER LPTX14$51.1M-28.5%
FAITH COMMUNITY HOSPITALTX13$40.2M9.0%
MEMORIAL HERMANN KINGWOODTX10$34.1M14.5%
CORNERSTONE REGIONAL HOSPITALTX14$26.3M3.3%
CHRISTUS MFH WINNSBOROTX14$24.3M15.1%
ALTUS HOUSTON HOSPITAL LPTX10$18.3M-45.7%
HANSFORD COUNTY HOSPITAL DISTRTX14$16.0M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $531K (749bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$149K+210bp18mo
Denial Rate Reduction12.0%6.5%$145K+204bp12mo
Cost to Collect4.5%2.5%$142K+200bp12mo
A/R Days Reduction5200.0%3800.0%$86K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+14bp6mo

5. EBITDA Bridge

Net Collection Rate
$149K
Denial Rate Reduction
$145K
Cost to Collect
$142K
A/R Days Reduction
$86K
Clean Claim Rate
$10K
Total EBITDA Uplift$531K
Current EBITDA$-8.4M
+ RCM Uplift+$531K
Pro Forma EBITDA$-7.9M
Current Margin-100.0%
Pro Forma Margin-110.8%
WC Released (1x)$272K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.9M$-50.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.9M$-59.2M0.00x-100.0%
Bull Case9.0x11.0x$-11.6M$-61.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.6M$-70.6M0.00x-100.0%
Bear Case11.0x10.0x$-14.2M$-48.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-14.2M$-57.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 82.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 5.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 23 hospitals with 4-14 beds
  • Same-state prioritization (n=36)
  • Comp margins: P25=-50.0% / P50=-40.3% / P75=-8.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.